In April 2025, a scientific meeting was held on the European side of Istanbul, bringing together physicians and pharmacists to explore the latest insights into saffron. The session featured Dr. Ahmet Aydınalp, who presented an in-depth overview of saffron’s historical significance and its growing role in modern medicine, supported by clinical research.

The healthcare professionals in attendance expressed strong curiosity about the recent studies on saffron, particularly its potential as a natural alternative for mood support. The discussions focused on the plant's antidepressant-like effects and how it could offer a safer and gentler option compared to conventional treatments.

Many doctors raised concerns about the rising rates of antidepressant prescriptions in Türkiye. They shared their discomfort with the long-term dependence and side effects associated with these drugs, emphasizing the urgent need for effective, natural solutions.

Dr. Aydınalp highlighted scientific data indicating that saffron’s active compounds may positively influence serotonin regulation. Patented formulations like Safr’Inside were presented as key innovations for enhancing stability and clinical efficacy.

A dinner event following the meeting allowed for further personal engagement, where attendees continued discussing product applications and patient experiences. The event stood out as an important step toward integrating evidence-based phytotherapy into routine clinical practice.